Seminar: The BSG’s verdict on Rapiscan® – What pharmaceutical manufacturers need to know
31. Mar 2023 — Register Here
The seminar aims to understand the impact of the judgment of the Federal Social Court on Rapiscan on the pricing and benefit assessment of soloists in the pharmaceutical industry. Participants should develop an understanding of the legal aspects of the judgment as well as the impact on products, price negotiations and compensation for invalid discounts.
The seminar is aimed at specialists and managers in the pharmaceutical industry. In particular, employees in the following departments will benefit from participation:
- Market Access and Health Policy
EUCOPE’s Alexander Natz will be speaking at the event, discussing the cornerstones of drug reimbursement and what it means for AMNOG.